Equities

Nexgel Inc

NXGL:NAQ

Nexgel Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.15
  • Today's Change-0.35 / -10.00%
  • Shares traded282.58k
  • 1 Year change+83.14%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2.706.6113
Total Receivables, Net0.630.220.21
Total Inventory1.320.500.29
Prepaid expenses0.400.170.08
Other current assets, total------
Total current assets5.057.5114
Property, plant & equipment, net3.352.462.65
Goodwill, net1.130.310.31
Intangibles, net0.330.020.03
Long term investments------
Note receivable - long term------
Other long term assets0.100.060.06
Total assets9.961017
LIABILITIES
Accounts payable1.230.270.25
Accrued expenses0.290.340.27
Notes payable/short-term debt0.2502.04
Current portion long-term debt/capital leases0.080.020.01
Other current liabilities, total0.700.240.32
Total current liabilities2.550.862.89
Total long term debt0.510.270.27
Total debt0.840.282.31
Deferred income tax------
Minority interest0.47----
Other liabilities, total1.731.591.74
Total liabilities5.262.724.90
SHAREHOLDERS EQUITY
Common stock0.010.010.01
Additional paid-in capital191919
Retained earnings (accumulated deficit)(15)(12)(6.81)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity4.707.6412
Total liabilities & shareholders' equity9.961017
Total common shares outstanding5.745.585.57
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.